Showing results (91-100 of 142) with videos related to

Sort By:
Pageof 15
Regulatory Peptides|November 4, 2008
The non-peptide kinin receptor antagonists FR 173657 and SSR 240612: preclinical evidence for the treatment of skin inflammationEvelise Fernandes Pietrovski, Michel Fleith Otuki, Domenico Regoli, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 3, 2007
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vivo studiesAnna Rizzi, Elaine C Gavioli, Giuliano Marzola, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 26, 2001
[Arg(14),Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studiesDaniela Rizzi, Anna Rizzi, Raffaella Bigoni, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 31, 2002
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agentsValeria Camarda, Anna Rizzi, Girolamo Calò, et al.
Stroke|March 8, 2003
Selective neuromicrovascular endothelial cell death by 8-Iso-prostaglandin F2alpha: possible role in ischemic brain injurySonia Brault, Ana Katherine Martinez-Bermudez, Anne Marilise Marrache, et al.
Peptides|July 27, 2005
Angiotensin II-induced increase of T-type Ca2+ current and decrease of L-type Ca2+ current in heart cellsGhassan Bkaily, Adrian Sculptoreanu, Shimin Wang, et al.
Frontiers in Pharmacology|September 21, 2018
Mouse Mast Cell Protease 4 Deletion Protects Heart Function and Survival After Permanent Myocardial InfarctionMartin Houde, Adel Schwertani, Hanène Touil, et al.
Pharmaceutics|September 27, 2025
Theranostic Potential of a New 64Cu-Labeled NOTA-R954 Peptide Conjugate for Kinin B1R Expressing Prostate CancerSadaf Ghanaatgar Kasbi, Martin Savard, Frédéric Couture, et al.
Pain|May 16, 2006
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: pharmacological and genetic evidencesAnna Rizzi, Cristiano Nazzaro, G Giuliano Marzola, et al.
Peptides|September 8, 2007
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11)Erika Marzola, Valeria Camarda, Madura Batuwangala, et al.
Pageof 15